Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naftali Stern

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Harefuah|May 21, 2003
[Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension]Naftali Stern, Ehud Grossman, , et al.
Diabetes Care|February 15, 2008
Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"?Etty Osher, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
Fat cell-derived modulators of vascular cell pathophysiology: the list keeps growingYonit Marcus, Naftali Stern
Clinical Endocrinology|February 19, 2009
How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery?Yona Greenman, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHANaftali Stern, Yelena Izkhakov
Journal of Clinical Hypertension (Greenwich, Conn.)|January 1, 2016
Blood Pressure Seasonality in Diabetic Patients: A Call for AttentionYonit Marcus, Naftali Stern
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Non-functioning pituitary adenomasYona Greenman, Naftali Stern
Endocrine|July 17, 2015
Optimal management of non-functioning pituitary adenomasYona Greenman, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
Perivascular fat: innocent bystander or active player in vascular disease?Naftali Stern, Yonit Marcus
Current Hypertension Reports|March 11, 2004
Hypertension in diabetes: the role of the vasculatureNaftali Stern, Yonit Marcus
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Harefuah|May 21, 2003
[Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension]Naftali Stern, Ehud Grossman, , et al.
Diabetes Care|February 15, 2008
Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"?Etty Osher, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
Fat cell-derived modulators of vascular cell pathophysiology: the list keeps growingYonit Marcus, Naftali Stern
Clinical Endocrinology|February 19, 2009
How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery?Yona Greenman, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHANaftali Stern, Yelena Izkhakov
Journal of Clinical Hypertension (Greenwich, Conn.)|January 1, 2016
Blood Pressure Seasonality in Diabetic Patients: A Call for AttentionYonit Marcus, Naftali Stern
Best Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2009
Non-functioning pituitary adenomasYona Greenman, Naftali Stern
Endocrine|July 17, 2015
Optimal management of non-functioning pituitary adenomasYona Greenman, Naftali Stern
Journal of the Cardiometabolic Syndrome|August 8, 2007
Perivascular fat: innocent bystander or active player in vascular disease?Naftali Stern, Yonit Marcus
Current Hypertension Reports|March 11, 2004
Hypertension in diabetes: the role of the vasculatureNaftali Stern, Yonit Marcus
Pageof 15